Εμφάνιση απλής εγγραφής

dc.creatorNikolaou M., Nikolaou G., Digklia A., Pontas C., Tsoukalas N., Kyrgias G., Tolia M.en
dc.date.accessioned2023-01-31T09:40:18Z
dc.date.available2023-01-31T09:40:18Z
dc.date.issued2019
dc.identifier10.1177/1534735419827090
dc.identifier.issn15347354
dc.identifier.urihttp://hdl.handle.net/11615/77213
dc.description.abstractOncology is currently a sector of medical science with accelerated progress due to rapid technological development, the advancement in molecular biology, and the invention of many innovative therapies. Immunotherapy partially accounts for this advance, since it is increasingly playing an important role in the treatment of cancer patients, bringing on a sense of hope and optimism through a series of clinical studies and cases with spectacular results. Immunotherapy, after the initial successes it experienced in the early 20th century, was forgotten after chemotherapy and radiotherapy prevailed and developed slowly in the background. Today, it is the new hope for cancer treatment, despite the unorthodox path it has followed. In this article, we study the course and key points of the discovery of immune-oncology from the oncologist’s point of view. We also record the questions that have been posed about immunotherapy that sometimes lead to confusion or stalemate. © The Author(s) 2019.en
dc.language.isoenen
dc.sourceIntegrative Cancer Therapiesen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85060990476&doi=10.1177%2f1534735419827090&partnerID=40&md5=f3fb93ab48d6871392daacde1a9256e1
dc.subjectatezolizumaben
dc.subjectavelumaben
dc.subjectcarboplatinen
dc.subjectdurvalumaben
dc.subjectimmunological antineoplastic agenten
dc.subjectipilimumaben
dc.subjectnivolumaben
dc.subjectpembrolizumaben
dc.subjectpemetrexeden
dc.subjectbladder canceren
dc.subjectcancer combination chemotherapyen
dc.subjectcancer immunotherapyen
dc.subjectcolitisen
dc.subjectconstipationen
dc.subjectcoughingen
dc.subjectdecreased appetiteen
dc.subjectdiarrheaen
dc.subjectdrug approvalen
dc.subjectendocrine diseaseen
dc.subjectfatigueen
dc.subjectfeveren
dc.subjecthead and neck canceren
dc.subjecthepatitisen
dc.subjecthistory of medicineen
dc.subjectHodgkin diseaseen
dc.subjecthumanen
dc.subjectkidney canceren
dc.subjectlarge cell lymphomaen
dc.subjectliver cell carcinomaen
dc.subjectmalignant neoplasmen
dc.subjectmelanomaen
dc.subjectmerkel cell carcinomaen
dc.subjectmetastatic colorectal canceren
dc.subjectmetastatic melanomaen
dc.subjectmusculoskeletal painen
dc.subjectnauseaen
dc.subjectnephritisen
dc.subjectnon small cell lung canceren
dc.subjectnonhumanen
dc.subjectoncologisten
dc.subjectpneumoniaen
dc.subjectpriority journalen
dc.subjectpruritusen
dc.subjectrashen
dc.subjectrenal cell carcinomaen
dc.subjectReviewen
dc.subjectskin toxicityen
dc.subjectsmall cell lung canceren
dc.subjectstomach canceren
dc.subjectuterine cervix canceren
dc.subjectimmunologyen
dc.subjectimmunotherapyen
dc.subjectneoplasmen
dc.subjectoncologyen
dc.subjectproceduresen
dc.subjectHumansen
dc.subjectImmunotherapyen
dc.subjectMedical Oncologyen
dc.subjectNeoplasmsen
dc.subjectSAGE Publications Inc.en
dc.titleImmunotherapy of Cancer: Developments and Reference Points, an Unorthodox Approachen
dc.typeotheren


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής